2931 - 2940 of 8801 Results
Title
Year
-
RESTRICTEDTitle: Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s diseaseJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 6Start Page: 550End Page: 565Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00071-1Citation Count: 43
-
RESTRICTEDTitle: Dysregulated miRNAs mark Parkinson’s disease progressionJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 3Start Page: 241End Page: 242Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00046-2Citation Count: 1
-
RESTRICTEDTitle: Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?Journal Name: Nature Reviews NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 2Start Page: 115End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41583-021-00542-9Citation Count: 198
-
RESTRICTEDTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 17
-
RESTRICTEDTitle: PINK1/Parkin-Mediated Mitophagy Plays a Protective Role in the Bone Impairment Caused by Aluminum ExposureJournal Name: Journal of Agricultural and Food ChemistryPublisher: American Chemical Society (ACS)Vol: 69Issue #: 21Start Page: 6054End Page: 6063Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jafc.1c01921Citation Count: 27
-
RESTRICTEDTitle: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarkerJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 10Start Page: 978End Page: 989Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0Citation Count: 40
-
OPENTitle: Deep brain stimulation for obsessive–compulsive disorder: a crisis of accessJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 8Start Page: 1529End Page: 1532Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-022-01879-zCitation Count: 67
-
RESTRICTEDTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xCitation Count: 103
-
RESTRICTEDTitle: Aducanumab: look before leapingJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 9Start Page: 1499End Page: 1499Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01477-5Citation Count: 11
-
OPENTitle: The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemicsJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 6Start Page: 615End Page: 623Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14737175.2021.1923480Best OA location URL: http://hdl.handle.net/11577/3395097Citation Count: 16